Key points are not available for this paper at this time.
Tobacco companies are investing billions in pharmaceutical and medical products. These ties complicate the ongoing efforts of researchers, scientific organisations, and journals to distance themselves from the industry, find Irene van den Berg, Mathilde de Jeu, and Hristio Boytchev
Berg et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: